放射基因组学:在直肠癌管理中的当代应用
Niall J O'Sullivan1,2,3, Hugo C Temperley4, Michelle T Horan1,2,3
1Department of Radiology, St. James's Hospital, D08 NHY1 Dublin, Ireland.
Cancers
|December 23, 2023
概括
放射基因组学使用成像来预测瘤生物学,为遗传检测提供了一个不那么侵入性的替代方案. 本综述探讨了它在直肠癌中用于预测瘤特征和结果的用途.
科学领域:
- 在瘤学瘤学.
- 放射学 放射学是一门学科.
- 基因组学就是基因组学.
背景情况:
- 放射基因组学,放射学的一个分支,使用成像标记物预测瘤生物学.
- 它的目的是用非侵入性的"成像生物标志物"取代侵入性基因测试.
- 潜在的应用包括评估瘤负担,异质性和纵向生物学.
研究的目的:
- 系统地审查关于直肠癌放射基因组学的文献.
- 通过放射遗传学方法评估潜在瘤生物学预测.
主要方法:
- 系统的文献审查.
- 对调查直肠癌中的放射基因组学研究的研究分析.
主要成果:
- 现有研究表明,放射遗传学特征可用于预测瘤特征和结果.
- 一个显著的局限性是许多研究缺乏前性,外部验证.
结论:
- 放射基因组学显示出作为一种非侵入性工具的承诺,用于表征直肠癌生物学.
- 进一步验证对于放射性基因组生物标志物的临床翻译至关重要.
相关概念视频
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...